Albany International reports Q1 2026 results on April 30 with its stock outpacing most of its peer group — a divergence that makes the print a clear test of whether the recent re-rating has fundamental support.
The price action alone sets up an interesting contrast. AIN has climbed 14% over the past month to $58.02, adding 5.3% on Wednesday alone and 4% on the week. Most correlated peers moved the other way: CR fell 2.8% on the day and KAI dropped 2.1%, while ASTE was a notable exception, rising 3.2%. The divergence suggests AIN-specific positioning is driving recent flows rather than any sector tailwind.
Short interest adds very little to the bear case. At 1.8% of the free float — down nearly 19% over the past month — there is no meaningful short positioning heading into the print. Borrowing costs are negligible at 0.45%, and borrow availability is extremely loose; the lending pool is barely tapped, sitting well below the 52-week high utilization of 6.87%. The ORTEX short score of 30 is benign. None of this signals any squeeze dynamic or elevated short-side conviction.
Options positioning is difficult to read cleanly here. The put/call ratio of 7.79 looks extreme in isolation, but it has been running in this range for most of April and is fractionally below its 20-day average of 8.74 — a z-score of -0.22 implies essentially no deviation from recent norms. The current reading reflects an options market structure where puts simply dominate open interest, not a sudden shift into defensive positioning ahead of earnings.
The analyst consensus is stale — the most recent changes on record date to January 2026, with JP Morgan holding a Neutral rating and a $47 target set at that time. That target now sits well below the current $58 price, suggesting the Street's published views have not kept pace with the stock's move. The consensus mean of $56.25 is itself slightly below where AIN closed Wednesday. With valuation multiples expanding — PE has risen roughly 1.96 turns over the past month to 21.5x and EV/EBITDA has moved up 0.34 to 9.4x — the stock has re-rated materially without a corresponding lift in analyst conviction.
The earnings report will test whether Albany International's Q1 fundamentals justify a stock trading above where most published analyst targets have it, after a month that left most industrial peers behind.
See the live data behind this article on ORTEX.
Open AIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
